Skip to content

Genpact G Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively

Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively at other companies

UCT
Ultra Clean HoldingsUCTT
$100K0.0%
Celestica logo
CelesticaCLS
$1.62B-0.8%
Cognizant logo
CognizantCTSH
Plexus logo
PlexusPLXS
Gartner logo
GartnerIT
Fidelity National Information Services logo
Fidelity National Information ServicesFIS

Other financials

Income statement

See full
Revenue$1.3B+6.7%
Gross profit$471.7M+9.9%
Operating income$198.6M+8.1%
Net income$148.0M+13.1%
EPS (diluted)$0.86+17.8%

Balance sheet

See full
Cash & equivalents$578.1M+2.9%
Total debt$1.4B-4.9%
Total equity$2.5B+0.9%
Total assets$5.6B+14.8%

Cash flow

See full
Operating cash flow-$23.5M-158%
CapEx$23.9M+8.9%
Free cash flow-$47.5M-357%

Valuation

See full
Market cap$4.79B-28.5%

Profitability

See full
Gross margin36.3%+0.8pp
Operating margin14.8%-0.1pp
Net margin11%+0.2pp
FCF margin13%+0.6pp

Returns & leverage

See full
Return on equity23.1%+0.9pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Genpact in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Genpact’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Genpact's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Genpact's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively?
Genpact (G) reported common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively of $1.69M in Q1 2026.
How has Genpact's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively changed year-over-year?
Genpact's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively decreased by 3.1% year-over-year, from $1.74M to $1.69M.
What is the long-term trend for Genpact's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively?
Over 5 years (2020 to 2025), Genpact's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively has grown at a -2.1% compound annual growth rate (CAGR), from $1.89M to $1.7M.
What does common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively mean?
This represents the par value of the common shares issued and outstanding. It is a foundational component of shareholders' equity and reflects the legal capital contributed by shareholders. While often small in dollar terms, it tracks the number of shares issued and the company's basic ownership structure.